Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nat Commun. 2024 Aug 9;15(1):6804. doi: 10.1038/s41467-024-50710-5.
Genome-wide association studies implicate multiple loci in risk for systemic lupus erythematosus (SLE), but few contain exonic variants, rendering systematic identification of non-coding variants essential to decoding SLE genetics. We utilized SNP-seq and bioinformatic enrichment to interrogate 2180 single-nucleotide polymorphisms (SNPs) from 87 SLE risk loci for potential binding of transcription factors and related proteins from B cells. 52 SNPs that passed initial screening were tested by electrophoretic mobility shift and luciferase reporter assays. To validate the approach, we studied rs2297550 in detail, finding that the risk allele enhanced binding to the transcription factor Ikaros (encoded by IKZF1), thereby modulating expression of IKBKE. Correspondingly, primary cells from genotyped healthy donors bearing the risk allele expressed higher levels of the interferon / NF-κB regulator IKKε. Together, these findings define a set of likely functional non-coding lupus risk variants and identify a regulatory pathway involving rs2297550, Ikaros, and IKKε implicated by human genetics in risk for SLE.
全基因组关联研究提示系统性红斑狼疮(SLE)的多个位点与风险相关,但其中很少包含外显子变异,这使得系统性识别非编码变异对于破解 SLE 遗传学至关重要。我们利用 SNP-seq 和生物信息学富集,对 87 个 SLE 风险位点的 2180 个单核苷酸多态性(SNP)进行了检测,以研究其是否可能与 B 细胞中的转录因子和相关蛋白结合。通过电泳迁移率变动和荧光素酶报告基因检测,对通过初步筛选的 52 个 SNP 进行了测试。为了验证该方法,我们对 rs2297550 进行了详细研究,发现风险等位基因增强了与转录因子 Ikaros(由 IKZF1 编码)的结合,从而调节 IKBKE 的表达。相应地,携带风险等位基因的经基因分型的健康供体的原代细胞表达了更高水平的干扰素/NF-κB 调节因子 IKKε。总之,这些发现定义了一组可能的功能性狼疮风险非编码变异体,并确定了一个涉及 rs2297550、Ikaros 和 IKKε 的调控途径,该途径已被人类遗传学研究确定为 SLE 风险的相关途径。